Tamsulosin and other alpha-1 blockers are used primarily for benign prostatic hyperplasia (BPH). Zinc is the primary mineral stored in the prostate and is required for prostate health. Alpha-blocker use does not restore zinc stores depleted by BPH pathology itself — and the underlying prostatic zinc deficiency continues.
Leake et al. (Clin Biochem, 1984) — BPH prostate tissue has 65% less zinc than healthy prostate. Zinc inhibits 5-alpha reductase (the same enzyme that Proscar targets) naturally. Zinc deficiency is mechanistically linked to BPH progression.
Continued BPH progression despite symptom control, reduced immune function, impaired testosterone metabolism
Zinc picolinate 30–45mg daily with food. Particularly relevant for BPH patients — addresses an underlying deficiency that alpha-blockers don't treat.
View on Fullscript: Thorne Zinc PicolinateDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Alpha-blockers cause vasodilation, which combined with magnesium's natural vasodilatory effects can cause enhanced hypotension. More relevantly, BPH patients are often elderly men with concurrent cardiovascular conditions and magnesium deficiency. Alpha-blockers don't deplete magnesium directly but the cardiovascular context makes magnesium monitoring important.
Cardiovascular disease (common in alpha-blocker patients) is independently associated with magnesium deficiency. Mg deficiency amplifies alpha-blocker-induced orthostatic hypotension risk.
Enhanced orthostatic hypotension, dizziness, falls risk (significant in elderly BPH patients)
Magnesium glycinate 200–300mg daily. Start low given enhanced hypotension risk and titrate up. Take with food.
View on Fullscript: Thorne Magnesium BisglycinateDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Alpha-blockers treat BPH symptoms without addressing the underlying selenium and lycopene deficiencies associated with prostate pathology. Selenium deficiency is associated with both BPH and prostate cancer risk. This is a gap in standard care, not a drug-induced depletion per se.
SELECT trial (JNCI, 2011) — selenium involvement in prostate health. Kirsh et al. — lycopene inversely associated with prostate cancer risk. These nutrients address the underlying pathology that alpha-blockers merely manage symptomatically.
Continued BPH progression, elevated prostate cancer risk
Selenium 100–200mcg (selenomethionine). Lycopene 15–30mg from food (cooked tomatoes) or supplement. Discuss with urologist.
View on Fullscript: Life Extension Super Selenium ComplexDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Taking Alpha-Blockers? Build Your Replenishment Stack.
Our clinical intake tool accounts for your medications, health goals, and risk factors — and outputs a personalized supplement protocol rated against published clinical trials.
Open the Full Tool Suite